323 related articles for article (PubMed ID: 25698456)
1. An examination of prostate cancer trends in Australia, England, Canada and USA: Is the Australian death rate too high?
Feletto E; Bang A; Cole-Clark D; Chalasani V; Rasiah K; Smith DP
World J Urol; 2015 Nov; 33(11):1677-87. PubMed ID: 25698456
[TBL] [Abstract][Full Text] [Related]
2. Prostate cancer incidence and mortality rates and trends in the United States and Canada.
McDavid K; Lee J; Fulton JP; Tonita J; Thompson TD
Public Health Rep; 2004; 119(2):174-86. PubMed ID: 15192905
[TBL] [Abstract][Full Text] [Related]
3. Patterns and trends in prostate cancer incidence, survival, prevalence and mortality. Part I: international comparisons.
Quinn M; Babb P
BJU Int; 2002 Jul; 90(2):162-73. PubMed ID: 12081758
[TBL] [Abstract][Full Text] [Related]
4. Prostate-cancer mortality in the USA and UK in 1975-2004: an ecological study.
Collin SM; Martin RM; Metcalfe C; Gunnell D; Albertsen PC; Neal D; Hamdy F; Stephens P; Lane JA; Moore R; Donovan J
Lancet Oncol; 2008 May; 9(5):445-52. PubMed ID: 18424233
[TBL] [Abstract][Full Text] [Related]
5. Prostate cancer and prostate-specific antigen testing in New South Wales.
Smith DP; Supramaniam R; Marshall VR; Armstrong BK
Med J Aust; 2008 Sep; 189(6):315-8. PubMed ID: 18803534
[TBL] [Abstract][Full Text] [Related]
6. Changes in prostate cancer incidence, mortality and survival in relation to prostate specific antigen testing in New South Wales, Australia.
Luo Q; Yu XQ; Kahn C; Egger S; Patel MI; Grogan PB; Caruana M; Canfell K; Smith DP; O'Connell DL
Cancer Epidemiol; 2022 Jun; 78():102159. PubMed ID: 35447540
[TBL] [Abstract][Full Text] [Related]
7. International trends in prostate-cancer mortality in the "PSA ERA".
Oliver SE; May MT; Gunnell D
Int J Cancer; 2001 Jun; 92(6):893-8. PubMed ID: 11351313
[TBL] [Abstract][Full Text] [Related]
8. Interpreting trends in prostate cancer incidence and mortality in the five Nordic countries.
Kvåle R; Auvinen A; Adami HO; Klint A; Hernes E; Møller B; Pukkala E; Storm HH; Tryggvadottir L; Tretli S; Wahlqvist R; Weiderpass E; Bray F
J Natl Cancer Inst; 2007 Dec; 99(24):1881-7. PubMed ID: 18073376
[TBL] [Abstract][Full Text] [Related]
9. PSA screening and deaths from prostate cancer after diagnosis--a population based analysis.
Wachtel MS; Nelius T; Haynes AL; Dahlbeck S; de Riese W
Prostate; 2013 Sep; 73(12):1365-9. PubMed ID: 23649537
[TBL] [Abstract][Full Text] [Related]
10. Prostate cancer--testing, incidence, surgery and mortality.
Gibbons L; Waters C
Health Rep; 2003 May; 14(3):9-20. PubMed ID: 12816012
[TBL] [Abstract][Full Text] [Related]
11. Comparison of prostate cancer survival in Germany and the USA: can differences be attributed to differences in stage distributions?
Winter A; Sirri E; Jansen L; Wawroschek F; Kieschke J; Castro FA; Krilaviciute A; Holleczek B; Emrich K; Waldmann A; Brenner H;
BJU Int; 2017 Apr; 119(4):550-559. PubMed ID: 27208546
[TBL] [Abstract][Full Text] [Related]
12. Prostate cancer trends in Canada: rising incidence or increased detection?
Levy IG; Gibbons L; Collins JP; Perkins DG; Mao Y
CMAJ; 1993 Sep; 149(5):617-24. PubMed ID: 8364818
[TBL] [Abstract][Full Text] [Related]
13. Trends in Prostate Specific Antigen (PSA) testing and prostate cancer incidence and mortality in Australia: A critical analysis.
Pathirana T; Sequeira R; Del Mar C; Dickinson JA; Armstrong BK; Bell KJL; Glasziou P
Cancer Epidemiol; 2022 Apr; 77():102093. PubMed ID: 35026706
[TBL] [Abstract][Full Text] [Related]
14. Prostate cancer incidence and mortality in Portugal: trends, projections and regional differences.
Pina F; Castro C; Ferro A; Bento MJ; Lunet N
Eur J Cancer Prev; 2017 Sep; 26(5):404-410. PubMed ID: 27483413
[TBL] [Abstract][Full Text] [Related]
15. Trends in prostate cancer in the United States.
Brawley OW
J Natl Cancer Inst Monogr; 2012 Dec; 2012(45):152-6. PubMed ID: 23271766
[TBL] [Abstract][Full Text] [Related]
16. Trends in prostate cancer incidence, mortality and survival in England and Wales 1971-1998.
Majeed A; Babb P; Jones J; Quinn M
BJU Int; 2000 Jun; 85(9):1058-62. PubMed ID: 10848694
[TBL] [Abstract][Full Text] [Related]
17. Recent trends in prostate cancer mortality show a continuous decrease in several countries.
Bouchardy C; Fioretta G; Rapiti E; Verkooijen HM; Rapin CH; Schmidlin F; Miralbell R; Zanetti R
Int J Cancer; 2008 Jul; 123(2):421-429. PubMed ID: 18452171
[TBL] [Abstract][Full Text] [Related]
18. The impact of a two- versus three-yearly cervical screening interval recommendation on cervical cancer incidence and mortality: an analysis of trends in Australia, New Zealand, and England.
Simonella L; Canfell K
Cancer Causes Control; 2013 Sep; 24(9):1727-36. PubMed ID: 23832659
[TBL] [Abstract][Full Text] [Related]
19. Population-based analysis of prostate-specific antigen (PSA) screening in younger men (<55 years) in Australia.
Ranasinghe WK; Kim SP; Lawrentschuk N; Sengupta S; Hounsome L; Barber J; Jones R; Davis P; Bolton D; Persad R
BJU Int; 2014 Jan; 113(1):77-83. PubMed ID: 24053128
[TBL] [Abstract][Full Text] [Related]
20. Prostate cancer and prostate-specific antigen (PSA) screening in Austria.
Vutuc C; Schernhammer ES; Haidinger G; Waldhör T
Wien Klin Wochenschr; 2005 Jul; 117(13-14):457-61. PubMed ID: 16091872
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]